Skip to main content
Fig. 3 | BMC Medicine

Fig. 3

From: Benefits and harms of Risperidone and Paliperidone for treatment of patients with schizophrenia or bipolar disorder: a meta-analysis involving individual participant data and clinical study reports

Fig. 3

Display of the total number of events combined over the 35 studies for key safety outcomes by the source of data. See ‘Additional file 11: Table S10’ for sensitivity analysis for causes of deaths and gynecomastia cases and the forest plots in ‘Additional file 14: Fig S2’ provide the total pooled relative risks/risk difference estimates. ‘Additional file 9: Table S9’ provides the relative differences in reporting and the ratio of relative risks for TEAEs and TESAEs. TEAEs, treatment-emergent adverse events; TESAEs, treatment-emergent serious adverse events; AE, adverse event; CSR, clinical study report

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us